AMLX – amylyx pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $11.00 price target on the stock, up previously from $3.00.
Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023) [Yahoo! Finance]
Amylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results
Form SC 13G/A Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC
Form 10-Q Amylyx Pharmaceuticals, For: Sep 30
Form 8-K Amylyx Pharmaceuticals, For: Nov 07
Form 4 Amylyx Pharmaceuticals, For: Nov 04 Filed by: Klee Justin B.
Form SC 13G Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.